Global Arbovirus Testing Market to Reach $1.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Arbovirus Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 4% over the period 2020-2027. ELISA-based Tests, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$799.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR based Tests segment is readjusted to a revised 4.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $287.4 Million, While China is Forecast to Grow at 7.1% CAGR
The Arbovirus Testing market in the U.S. is estimated at US$287.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$297.6 Million by the year 2027 trailing a CAGR of 7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.We bring years of research experience to this 6th edition of our report. The 279-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Alere, Inc.
- Diamedix Corporation
- Euroimmun AG
- Focus Diagnostics, Inc.
- IBL International GmbH
- NovaTec Immundiagnostica GmbH
- Thermo Fisher Scientific, Inc.